Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
13. Dezember 2023 16:30 ET
|
Certara
Combined Certara-Applied Biomath organization establishes the life sciences industry’s largest quantitative systems pharmacology center.
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
21. November 2023 16:30 ET
|
Certara
Certara's Simcyp™ Biopharmaceutics software helps biopharmaceutic, formulation & CMC scientists formulate complex new and generic drugs faster and cheaper.
Certara Reports Third Quarter 2023 Financial Results
08. November 2023 16:10 ET
|
Certara
PRINCETON, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the third quarter of fiscal year 2023. ...
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
11. Oktober 2023 16:15 ET
|
Certara
PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023...
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
19. September 2023 08:15 ET
|
Certara
PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has successfully supported 300 completed submissions to...
Certara to Participate in Upcoming Investor Conferences
29. August 2023 16:15 ET
|
Certara
PRINCETON, N.J., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...
Certara Simcyp™ Group Awarded Two New Grants from US FDA
29. August 2023 08:15 ET
|
Certara
PRINCETON, N.J., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced that the Simcyp group has been awarded two new grants from the U.S. Food...
Certara Reports Second Quarter 2023 Financial Results
09. August 2023 16:15 ET
|
Certara
PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the second quarter of fiscal year 2023. ...
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
13. Juli 2023 16:30 ET
|
Certara
PRINCETON, N.J., July 13, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of...
Certara to Participate in the Jefferies Global Healthcare Conference
02. Juni 2023 16:15 ET
|
Certara
PRINCETON, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global...